Cargando…

Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields

Point of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead shields that reduce SPI and acquisition time. METHODS: Two concave lead shields, a semioval lead shield (OLS) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cañete-Sánchez, Francisco M., Boulvard-Chollet, Xavier L. E., Chamorro, Xabier, Marrodán, MArch, Pablo Javier, Garrastachu Zumarán, Puy, Ramírez Lasanta, Rafael, Colletti, Patrick M., Giammarile, Francesco, Delgado Bolton, Roberto C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169747/
https://www.ncbi.nlm.nih.gov/pubmed/35605055
http://dx.doi.org/10.1097/RLU.0000000000004274
_version_ 1784721264307339264
author Cañete-Sánchez, Francisco M.
Boulvard-Chollet, Xavier L. E.
Chamorro, Xabier
Marrodán, MArch, Pablo Javier
Garrastachu Zumarán, Puy
Ramírez Lasanta, Rafael
Colletti, Patrick M.
Giammarile, Francesco
Delgado Bolton, Roberto C.
author_facet Cañete-Sánchez, Francisco M.
Boulvard-Chollet, Xavier L. E.
Chamorro, Xabier
Marrodán, MArch, Pablo Javier
Garrastachu Zumarán, Puy
Ramírez Lasanta, Rafael
Colletti, Patrick M.
Giammarile, Francesco
Delgado Bolton, Roberto C.
author_sort Cañete-Sánchez, Francisco M.
collection PubMed
description Point of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead shields that reduce SPI and acquisition time. METHODS: Two concave lead shields, a semioval lead shield (OLS) and a semispherical lead alloy shield (SLS), were created with a SICNOVA JCR 1000 3D printer to cover the point of injection (patent no. ES1219895U). Twenty breast cancer patients had anterior and anterior oblique imaging, 5 minutes and 2 hours after a single 111 MBq nanocolloid in 0.2 mL intratumoral or periareolar injection. Each acquisition was 2 minutes. Absolute and normalized background corrected scatter counts (CSCs) and scatter reduction percentage (%SR) related to the FLS were calculated. Repositionings were recorded. Differences between means of %SR (t test) and between means of CSC (analysis of variance) with Holm multiple comparison tests were determined. RESULTS: Mean %SR was 91.8% with OLS and 92% using SLS in early images (P = 0.91) and 87.2%SR in OLS and 88.5% in late images (P = 0.66). There were significant differences between CSC using FLS and OLS (P < 0.001) and between FLS and SLS (P < 0.001), but not between OLS and SLS (P = 0.17) in early images, with the same results observed in delayed studies (P < 0.001 in relation to FLS and P = 0.1 between both curved lead shields). Repositioning was required 14/20 times with FLS, 4/20 times with OLS, and 2/20 times with SLS. CONCLUSIONS: We designed 2 concave lead shields that significantly reduce the SPI and repositioning with sentinel lymph node lymphoscintigraphy.
format Online
Article
Text
id pubmed-9169747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-91697472022-06-08 Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields Cañete-Sánchez, Francisco M. Boulvard-Chollet, Xavier L. E. Chamorro, Xabier Marrodán, MArch, Pablo Javier Garrastachu Zumarán, Puy Ramírez Lasanta, Rafael Colletti, Patrick M. Giammarile, Francesco Delgado Bolton, Roberto C. Clin Nucl Med Original Articles Point of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead shields that reduce SPI and acquisition time. METHODS: Two concave lead shields, a semioval lead shield (OLS) and a semispherical lead alloy shield (SLS), were created with a SICNOVA JCR 1000 3D printer to cover the point of injection (patent no. ES1219895U). Twenty breast cancer patients had anterior and anterior oblique imaging, 5 minutes and 2 hours after a single 111 MBq nanocolloid in 0.2 mL intratumoral or periareolar injection. Each acquisition was 2 minutes. Absolute and normalized background corrected scatter counts (CSCs) and scatter reduction percentage (%SR) related to the FLS were calculated. Repositionings were recorded. Differences between means of %SR (t test) and between means of CSC (analysis of variance) with Holm multiple comparison tests were determined. RESULTS: Mean %SR was 91.8% with OLS and 92% using SLS in early images (P = 0.91) and 87.2%SR in OLS and 88.5% in late images (P = 0.66). There were significant differences between CSC using FLS and OLS (P < 0.001) and between FLS and SLS (P < 0.001), but not between OLS and SLS (P = 0.17) in early images, with the same results observed in delayed studies (P < 0.001 in relation to FLS and P = 0.1 between both curved lead shields). Repositioning was required 14/20 times with FLS, 4/20 times with OLS, and 2/20 times with SLS. CONCLUSIONS: We designed 2 concave lead shields that significantly reduce the SPI and repositioning with sentinel lymph node lymphoscintigraphy. Lippincott Williams & Wilkins 2022-07 2022-05-19 /pmc/articles/PMC9169747/ /pubmed/35605055 http://dx.doi.org/10.1097/RLU.0000000000004274 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Articles
Cañete-Sánchez, Francisco M.
Boulvard-Chollet, Xavier L. E.
Chamorro, Xabier
Marrodán, MArch, Pablo Javier
Garrastachu Zumarán, Puy
Ramírez Lasanta, Rafael
Colletti, Patrick M.
Giammarile, Francesco
Delgado Bolton, Roberto C.
Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
title Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
title_full Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
title_fullStr Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
title_full_unstemmed Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
title_short Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields
title_sort sentinel node biopsy imaging in breast cancer: scatter reduction using 3-dimensionally printed lead shields
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169747/
https://www.ncbi.nlm.nih.gov/pubmed/35605055
http://dx.doi.org/10.1097/RLU.0000000000004274
work_keys_str_mv AT canetesanchezfranciscom sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT boulvardcholletxavierle sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT chamorroxabier sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT marrodanmarchpablojavier sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT garrastachuzumaranpuy sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT ramirezlasantarafael sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT collettipatrickm sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT giammarilefrancesco sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields
AT delgadoboltonrobertoc sentinelnodebiopsyimaginginbreastcancerscatterreductionusing3dimensionallyprintedleadshields